Lunai Bioworks Inc. Other Current Liabilities
Lunai Bioworks Inc. (LNAI) had Other Current Liabilities of $364.63 thousand as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-05-15
- 2026-03-31: Other Liabilities, Current $364.63K.
- 2025-12-31: Other Liabilities, Current $74.34K.
- 2025-09-30: Other Liabilities, Current $71.43K.
- 2025-06-30: Other Liabilities, Current $378.28K.
| Period end | Other Liabilities, Current |
|---|---|
| 2026-03-31 | $364.63K 10-Q · filed 2026-05-15 |
| 2025-12-31 | $74.34K 10-Q · filed 2026-02-17 |
| 2025-09-30 | $71.43K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $378.28K 10-Q · filed 2026-05-15 |
| 2025-03-31 | $546.26K 10-Q · filed 2025-05-15 |
| 2024-12-31 | $817.91K 10-Q · filed 2025-02-19 |
| 2024-09-30 | $102.74K 10-Q/A · filed 2025-02-19 |
| 2024-06-30 | $295.36K 10-K · filed 2025-09-29 |
| 2024-03-31 | $519.43K 10-Q/A · filed 2025-02-19 |
| 2023-12-31 | $669.38K 10-Q · filed 2024-02-14 |
| 2023-06-30 | $184.73K 10-Q/A · filed 2025-02-19 |
| 2023-03-31 | $501.05K 10-Q · filed 2023-05-12 |
| 2022-12-31 | $875.41K 10-Q · filed 2023-03-09 |
| 2022-09-30 | $35.54K 10-Q · filed 2023-03-07 |
| 2022-06-30 | $220.69K 10-K · filed 2023-10-02 |
| 2022-03-31 | $277.71K 10-Q · filed 2022-05-13 |
| 2021-12-31 | $499.88K 10-Q · filed 2022-02-14 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 |
| 2021-06-30 | $90.60K 10-K · filed 2023-02-27 |
| 2021-03-31 | $302.99K 10-Q · filed 2021-05-17 |
| 2020-12-31 | $484.79K 10-Q · filed 2021-02-16 |
| 2020-06-30 | $0.00 10-Q · filed 2021-05-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |